Company news
Patrys Limited news in 2018
Patrys Limited's news releases, calls and decks from 2018, newest first.
PAT-DX1 Suppresses Breast Cancer Brain Metastases
December 19, 2018
Appendix 4C - Quarterly - 30 September 2018
October 30, 2018
Settlement of Manufacturing Claims
October 24, 2018
PAT-DX1 Clinical Target Indications Confirmed
October 4, 2018
Patrys and WEHI Awarded Grant
August 28, 2018
Appendix 4E and 2018 Annual Report
August 24, 2018
Patent Granted for Pre-clinical IgM Candidate PAT-LM1
August 1, 2018
Appendix 4C - Quarterly - 30 June 2018
July 25, 2018
Preliminary PAT-DX1 pharmacokinetics
July 5, 2018
China and Japan both grant patents for Deoxymab 3E10
July 3, 2018
PAT-DX1 Targets and Kills Brain Cancer Stem Cells
May 30, 2018
Patrys Increases Capital Raising to $4.6 million
May 20, 2018
New Pre-Clinical Collaboration on PAT-DX1
May 16, 2018
Patrys Completes $3.5M Placement
May 15, 2018
Appendix 4C - Quarterly - 31 March 2018
April 26, 2018
PAT-DX1 Improves Survival in Animal Model of Glioblastoma
March 18, 2018
PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size
February 27, 2018
Appendix 4D - Half Year Accounts - 31 December 2017
February 23, 2018
Appendix 4C - Quarterly - 31 December 2017
January 31, 2018
Publication and Patent Filing for Humanized Version of 3E10
January 30, 2018
PAT-DX1-NP Localizes to Lymph Node Metastases
January 28, 2018
Entitlement Offer Booklet
January 14, 2018
Decks in 2018
- Shareholder Meeting (November 2018)
Shareholder meeting · 26 slides · Nov 22, 2018